Yi Li

Title: Yi Li - Innovator in Monoclonal Antibody Research

Introduction

Yi Li is a prominent inventor based in Seattle, WA, known for his significant contributions to the field of monoclonal antibodies. His innovative work focuses on the detection of complement factor D, which plays a crucial role in the immune system.

Latest Patents

Yi Li holds a patent for "Monoclonal antibodies, compositions and methods for detecting complement factor D." This patent discloses monoclonal antibodies that specifically bind to human mature Factor D and do not bind to human Pro-Factor D. Additionally, it includes antibodies that specifically bind to human Pro-Factor D and do not bind to human mature Factor D, as well as those that bind to both forms. The patent also outlines methods for using these antibodies to detect the status of the Alternative Pathway of Complement (APC) in biological samples.

Career Highlights

Yi Li is currently associated with Omeros Corporation, where he continues to advance his research in monoclonal antibodies. His work has the potential to impact various medical applications, particularly in understanding and treating conditions related to the immune system.

Collaborations

Some of Yi Li's notable coworkers include William Jason Cummings and Jeremy A Freeman, who contribute to the collaborative environment at Omeros Corporation.

Conclusion

Yi Li's innovative research in monoclonal antibodies represents a significant advancement in the field of immunology. His contributions are paving the way for new diagnostic methods and therapeutic approaches.